Retinal Vascular Network and Obstructive Sleep Apnea
ORNET
Pilot Study: Retinal Vascular Network and Obstructive Sleep Apnea
1 other identifier
observational
166
1 country
1
Brief Summary
Obstructive sleep apnea syndrome (OSA) is thought to lead to systemic vascular lesions that may be preceded by early microvascular lesions in the eyes and in particular in the retina. The improvement of ophthalmological imaging techniques by OCTangiography allows a precise non-invasive study of the retinal microvascular network. This new rapid and non-invasive retinal imaging tool could reveal micro-vascular lesions related to OSA. To the investigator's knowledge, this would be the first OCT-angiography description of a cohort of patients with OSA. If these results are confirmed, it would be interesting to study the correlation between these micro-vascular lesions and the cardiovascular risk of his patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2019
CompletedFirst Posted
Study publicly available on registry
June 7, 2019
CompletedStudy Start
First participant enrolled
January 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 22, 2024
CompletedFebruary 17, 2026
February 1, 2026
4.6 years
June 5, 2019
February 12, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Measurement of macular and peri-papillary retinal vascular density of the superficial and deep capillary plexuses
Change from baseline at 24 months
Measurement of macular and peri-papillary retinal infusion density of the superficial and deep capillary plexuses
Change from baseline at 24 months
Measurement of the surface of the macular avascular zone of the superficial and deep capillary plexuses
Change from baseline at 24 months
Study Arms (2)
Patients
Patients referred for polysomnography diagnosis of obstructive sleep apnea syndrome
Controls
Person without obstructive sleep apnea syndrome
Interventions
collection: * ophthalmological history and current treatments * occular tension measurement * measurement of visual acuity (Snellen chart) * Axial length measurement * Photograph of the posterior segment of the eye * 3x3 and 6x6 macular and papillary OCT angiography
Eligibility Criteria
Patients seen for sleep apnea screening by a pulmonologist and referred for polysomnography diagnosis of obstructive sleep apnea syndrome
You may qualify if:
- person who has given oral consent
- person who can be followed throughout the study
- adult
- Patient group:
- \- Patient seen in sleep apnea screening consultation by a pulmonologist and referred for polysomnography diagnosis of OSA
- Control Group:
- \- Person initially without obstructive sleep apnea syndrome
You may not qualify if:
- a person who is not affiliated to or not a beneficiary of the national health insurance system
- person subject to a measure of legal protection (curatorship, guardianship)
- person subject to a safeguard of justice
- pregnant, parturient or breastfeeding woman
- adult incapable or unable to consent
- person with a contraindication to Tropicamide or Neosynephrine
- person with a history of eye disease affecting ocular circulation (examples: acute anterior ischemic optic neuropathy, retinal central artery occlusion, retinal central vein occlusion, diabetic retinopathy, glaucoma, uncontrolled hypertonia, AMD, severe myopia...)
- Control Group:
- person with a history of chronic lung problems (e.g. COPD, chronic respiratory failure, etc.)
- person with at least one of the following risk factors for obstructive sleep apnea syndrome:
- Obesity with IMC≥30
- Alcohol consumption \> 3 glasses per day
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Dijon Bourogne
Dijon, 21000, France
Related Publications (1)
Germanese C, Georges M, Bonniaud P, Goueslard K, Arnould L, Creuzot Garcher C, Gabrielle PH. Characterization of Retinal Microvascular Changes in Obstructive Sleep Apnea Using OCT Angiography: Data from the Obstructive Sleep Apnea and Retinal Microvascular NETwork Study. Ophthalmology. 2026 Feb 2:S0161-6420(26)00059-X. doi: 10.1016/j.ophtha.2026.01.030. Online ahead of print.
PMID: 41638537RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2019
First Posted
June 7, 2019
Study Start
January 6, 2020
Primary Completion
August 22, 2024
Study Completion
August 22, 2024
Last Updated
February 17, 2026
Record last verified: 2026-02